Key Financial Data Of Group

KOBAYASHI PHARMACEUTICAL CO.,LTD. - Filing #7270714

Concept As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
Key financial data of group
Business results of group
Net sales
126,658,000,000 JPY
165,600,000,000 JPY
173,455,000,000 JPY
139,303,000,000 JPY
166,258,000,000 JPY
132,167,000,000 JPY
129,585,000,000 JPY
155,252,000,000 JPY
150,514,000,000 JPY
129,733,000,000 JPY
Ordinary profit (loss)
26,343,000,000 JPY
26,861,000,000 JPY
27,330,000,000 JPY
24,246,000,000 JPY
28,281,000,000 JPY
24,535,000,000 JPY
23,512,000,000 JPY
28,015,000,000 JPY
27,726,000,000 JPY
25,314,000,000 JPY
Profit (loss) attributable to owners of parent
10,067,000,000 JPY
20,338,000,000 JPY
20,022,000,000 JPY
19,715,000,000 JPY
19,205,000,000 JPY
Comprehensive income
15,921,000,000 JPY
25,957,000,000 JPY
22,801,000,000 JPY
23,160,000,000 JPY
15,710,000,000 JPY
Net assets
172,549,000,000 JPY
213,471,000,000 JPY
204,816,000,000 JPY
169,626,000,000 JPY
197,900,000,000 JPY
167,895,000,000 JPY
170,785,000,000 JPY
195,600,000,000 JPY
163,454,000,000 JPY
182,583,000,000 JPY
Total assets
217,933,000,000 JPY
265,368,000,000 JPY
267,473,000,000 JPY
223,936,000,000 JPY
255,827,000,000 JPY
219,400,000,000 JPY
222,250,000,000 JPY
252,554,000,000 JPY
215,141,000,000 JPY
238,366,000,000 JPY
Net assets per share
2,311.87
2,862.28
2,749.17
2,275.79
2,600.04
2,205.31
2,196.31
2,515.53
2,091.20
2,335.93
Basic earnings (loss) per share
141.80
135.42
268.16
238.06
259.63
235.58
218.07
252.36
245.71
223.82
Diluted earnings per share
259.59
235.54
Equity-to-asset ratio
0.789 xbrli:pure
0.802 xbrli:pure
0.764 xbrli:pure
0.755 xbrli:pure
0.773 xbrli:pure
0.764 xbrli:pure
0.768 xbrli:pure
0.774 xbrli:pure
0.760 xbrli:pure
0.766 xbrli:pure
Rate of return on equity
0.062 xbrli:pure
0.048 xbrli:pure
0.101 xbrli:pure
0.107 xbrli:pure
0.102 xbrli:pure
0.107 xbrli:pure
0.102 xbrli:pure
0.104 xbrli:pure
0.108 xbrli:pure
0.110 xbrli:pure
Price-earnings ratio
43.9 xbrli:pure
46.0 xbrli:pure
25.3 xbrli:pure
28.5 xbrli:pure
34.8 xbrli:pure
38.3 xbrli:pure
41.5 xbrli:pure
35.8 xbrli:pure
51.3 xbrli:pure
56.3 xbrli:pure
Net cash provided by (used in) operating activities
11,246,000,000 JPY
18,360,000,000 JPY
31,914,000,000 JPY
22,419,000,000 JPY
23,986,000,000 JPY
Net cash provided by (used in) investing activities
-18,415,000,000 JPY
-19,576,000,000 JPY
-14,312,000,000 JPY
7,991,000,000 JPY
-12,656,000,000 JPY
Net cash provided by (used in) financing activities
-7,768,000,000 JPY
-19,463,000,000 JPY
-20,759,000,000 JPY
-10,377,000,000 JPY
-6,019,000,000 JPY
Cash and cash equivalents
45,973,000,000 JPY
59,690,000,000 JPY
79,480,000,000 JPY
81,987,000,000 JPY
61,157,000,000 JPY
Number of employees
117 xbrli:pure
34 xbrli:pure
317 xbrli:pure
1,665 xbrli:pure
2,178 xbrli:pure
1,314 xbrli:pure
1,003 xbrli:pure
3,181 xbrli:pure
1,348 xbrli:pure
xbrli:pure
317 xbrli:pure
3,615 xbrli:pure
3,534 xbrli:pure
1,645 xbrli:pure
3,495 xbrli:pure
1,631 xbrli:pure
1,607 xbrli:pure
3,451 xbrli:pure
1,589 xbrli:pure
3,473 xbrli:pure
Average number of temporary employees
107 xbrli:pure
xbrli:pure
16 xbrli:pure
99 xbrli:pure
314 xbrli:pure
83 xbrli:pure
1 xbrli:pure
315 xbrli:pure
83 xbrli:pure
xbrli:pure
16 xbrli:pure
438 xbrli:pure
472 xbrli:pure
117 xbrli:pure
518 xbrli:pure
151 xbrli:pure
151 xbrli:pure
528 xbrli:pure
154 xbrli:pure
542 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.